Relapsing-Remitting Multiple Sclerosis (RRMS): Clinical Trials

1 trial for Relapsing-Remitting Multiple Sclerosis (RRMS), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Relapsing-Remitting Multiple Sclerosis (RRMS): new trials by email Literature Review of Relapsing-Remitting Multiple Sclerosis (RRMS) trials Research Report on Relapsing-Remitting Multiple Sclerosis (RRMS)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Plegridy Satisfaction Study in Participants
peginterferon beta-1a - Relapsing-Remitting Multiple Sclerosis (RRMS)
Phase 4CompletedBiogen1932016-02-032023-08-31

Narrower conditions

Multiple Sclerosis, Relapsing-Remitting (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Immune System Diseases (1)  ·  Multiple Sclerosis (1)  ·  Nervous System Diseases (1)

Interventions

peginterferon beta-1a (1)

Sponsors

Biogen (1)

Countries

Italy (1)

NIH funding

2015 (1)